Stigmasta-3,5-Diene | CAS 4970-37-0 - Request Quote
Stigmasta-3,5-Diene
| SZ CAT No: | SZ-S100008 |
| CAS No | 4970-37-0 |
| Mol.F. | C29H48 |
| Mol.Wt. | 396.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Stigmasta-3,5-Diene is chemically (8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene. Stigmasta-3,5-Diene is supplied with detailed characterization data compliant with regulatory guideline. Stigmasta-3,5-Diene can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Stigmastanol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 4970-37-0
Purchase 4970-37-0
Order 4970-37-0
Enquire 4970-37-0
price of 4970-37-0
4970-37-0 Supplier
4970-37-0 Manufacturer
4970-37-0 Exporter
buy high quality Stigmasta-3,5-Diene
Purchase Stigmasta-3,5-Diene
Stigmasta-3,5-Diene suppliers
Stigmasta-3,5-Diene manufacturers
Stigmasta-3,5-Diene price
Order Stigmasta-3,5-Diene
Enquire Stigmasta-3,5-Diene
Stigmasta-3,5-Diene cost
Stigmasta-3,5-Diene Supplier
Stigmasta-3,5-Diene Distributor
Stigmasta-3,5-Diene for Method Validation
Stigmastanol Reference Standard
Stigmasta-3,5-Diene for ANDA Filing
Stigmasta-3,5-Diene for Forced Degradation Studies
Stigmasta-3,5-Diene Identification Standards
Stigmasta-3,5-Diene for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


